$2.02
-0.02 (-0.98%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,577.7% upside
Low Target
$29.33
Average Target
$33.89
High Target
$54.04
Current Price
$2.02
Current
$2.02
$2.02
Target
$33.89
$33.89
$29.33
$33.89 avg
$54.04
Scenario Analysis
Bear Case
$29.33
1,352.0%
Low target
Base Case
$33.89
+1,577.7%
Avg target
Bull Case
$54.04
+2,575.2%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$3.95
-48.9% from high
52-Week Low
$1.56
+29.5% from low
Target vs 52W High
$33.89
+758.0% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -3.3% |
| AMGN | Hold | 43 | 47% | $190.87 | -54.4% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +138.3% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -16.9% |
| REGN | Buy | 38 | 68% | $76.80 | -89.8% |
| MRNA | Hold | 30 | 37% | $149.45 | -24.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.3% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -43.4% |